The data described so far imply the IGF1‐R/AKT pathway in Tel activity on FOXA1 and ERα protein levels and function and correlate FOXA1 with cell sensitivity to Tel antiproliferative effect in breast and non‐breast tumor cell lines. The gene discussed is AKT1; the disease is breast neoplasm.